Tropisetron modulates peripheral and central serotonin/insulin levels via insulin and nuclear factor kappa B/receptor for advanced glycation end products signalling to regulate type-2 diabetes in rats
| dc.Affiliation | October University for modern sciences and Arts (MSA) | |
| dc.contributor.author | Ali Mohamed, Reem | |
| dc.contributor.author | Galal, Omneya | |
| dc.contributor.author | Refaat Mohammed, Ahmed | |
| dc.contributor.author | Salah El-Abhar, Hanan | |
| dc.date.accessioned | 2020-02-02T07:32:08Z | |
| dc.date.available | 2020-02-02T07:32:08Z | |
| dc.date.issued | 2018 | |
| dc.description | MSA Google Scholar | en_US |
| dc.description.abstract | Despite its known central effect, 5% of serotonin is found centrally, while around 95% is found peripherally. Serotonin is stored and co-released with insulin upon pancreatic islets stimulation by glucose. This fact raises the curiosity regarding its possible role in diabetes. Hence, in this study, we assessed the possible modulatory effects of tropisetron, a 5-HT3 receptor antagonist, on type 2 diabetes mellitus models in rats. The rats were allocated into two groups: normal and diabetic. The latter group was treated with metformin (500 mg kg−1, p.o.), tropisetron (1 and 2 mg kg−1, i.p.), and a combination of metformin and tropisetron (1 mg kg−1). The different treatment regimens corrected glucose and lipid homeostasis manifested by the decrease in serum levels of glucose, fructosamine, homeostasis model of insulin resistance, triglycerides, total cholesterol, free fatty acid, as well as receptor for advanced glycation end products. Additionally, the treatments elevated levels of insulin, serotonin, and homeostasis model of β-cell function. On the molecular level, treatments corrected the altered insulin signaling cascade (phosphorylated insulin receptor substrate 1, phosphorylated protein kinase B, and glucose transporter 4), and inhibited β-catenin and phosphorylated nuclear factor kappa B p65 in the assessed soleus skeletal muscle. A similar pattern was duplicated in the hippocampus. This study provided evidence for the role of tropisetron on type 2 diabetes mellitus via modulating the insulin signaling cascade (insulin, phosphorylated insulin receptor substrate 1, phosphorylated protein kinase B, and glucose transporter 4), improving lipid/glucose profile, decreasing inflammatory markers (receptor for advanced glycation end products, and phosphorylated nuclear factor kappa B p65), as well as increasing 5-HT and reducing β-catenin. | en_US |
| dc.description.sponsorship | The Royal Society of Chemistry | en_US |
| dc.description.uri | https://www.scimagojr.com/journalsearch.php?q=21100199840&tip=sid&clean=0 | |
| dc.identifier.citation | J. Tseung, Pathology, 2005, 37, 190 CrossRef . M. Azevedo and S. Alla, Int. J. Diabetes Dev. Countries, 2008, 28, 101–108 CrossRef PubMed . A. D. Association, Diabetes Care, 2014, 37, S81–S90 CrossRef PubMed . M. Y. Donath and S. E. Shoelson, Nat. Rev. Immunol., 2011, 11, 98–107 CrossRef CAS PubMed . R. P. Robertson, J. Harmon, P. O. T. Tran and V. Poitout, Diabetes, 2004, 53, S119–S124 CrossRef CAS PubMed . R. L. Hull, G. T. Westermark, P. Westermark and S. E. Kahn, J. Clin. Endocrinol. Metab., 2004, 89, 3629–3643 CrossRef CAS PubMed . D. E. Kelley, J. He, E. V. Menshikova and V. B. Ritov, Diabetes, 2002, 51, 2944–2950 CrossRef CAS PubMed . E. R. Seaquist, Diabetes, 2010, 59, 4–5 CrossRef CAS PubMed . D. Gupta, D. Thangaraj and M. Radhakrishnan, Behav. Brain Res., 2016, 297, 41–50 CrossRef CAS PubMed . J. Zemdegs, G. Quesseveur, D. Jarriault, L. Pénicaud, X. Fioramonti and B. P. Guiard, Br. J. Pharmacol., 2015, 173, 2095–2110 CrossRef PubMed . S. Gold, I. Dziobek, V. Sweat, A. Tirsi, K. Rogers, H. Bruehl, W. Tsui, S. Richardson, E. Javier and A. Convit, Diabetologia, 2007, 50, 711–719 CrossRef CAS PubMed . N. Paulmann, M. Grohmann, J.-P. Voigt, B. Bert, J. Vowinckel, M. Bader, M. Skelin, M. Jevšek, H. Fink and M. Rupnik, PLoS Biol., 2009, 7, e1000229 Search PubMed . D. Mechlovich, T. Amit, O. Bar-Am, O. Weinreb and M. B. Youdim, Br. J. Pharmacol., 2014, 171, 5636–5649 CrossRef CAS PubMed . S. A. El-Marasy, H. M. Abdallah, S. M. El-Shenawy, A. S. El-Khatib, O. A. El-Shabrawy and S. A. Kenawy, Can. J. Physiol. Pharmacol., 2014, 92, 945–952 CrossRef CAS PubMed . E. Nicole, E. J. Barry, C. Pinelli, G. A. Wood, D. B. Hardy, K. M. Morrison, V. H. Taylor, H. C. Gerstein and A. C. Holloway, Toxicol. Appl. Pharmacol., 2015, 285, 32–40 CrossRef PubMed . M. Iwabayashi, Y. Taniyama, J. Azuma, F. Sanada, K. Iekushi, H. Rakugi and R. Morishita, in Biochemical Basis and Therapeutic Implications of Angiogenesis, Springer, 2013, pp. 225–238 Search PubMed . P. Amireault, D. Sibon and F. Côté, ACS Chem. Neurosci., 2012, 4, 64–71 CrossRef PubMed . L. Bouwens and I. Rooman, Physiol. Rev., 2005, 85, 1255–1270 CrossRef CAS PubMed . S. Rieck, P. White, J. Schug, A. J. Fox, O. Smirnova, N. Gao, R. K. Gupta, Z. V. Wang, P. E. Scherer and M. P. Keller, Mol. Endocrinol., 2009, 23, 1702–1712 CrossRef CAS PubMed . H. Kim, Y. Toyofuku, F. C. Lynn, E. Chak, T. Uchida, H. Mizukami, Y. Fujitani, R. Kawamori, T. Miyatsuka and Y. Kosaka, Nat. Med., 2010, 16, 804–808 CrossRef CAS PubMed . K. Heimes, B. Feistel and E. J. Verspohl, Eur. J. Pharmacol., 2009, 624, 58–65 CrossRef CAS PubMed . R. Vleugels, H. Verlinden and J. Vanden Broeck, Neurotransmitter, 2015, 2, 1–14 Search PubMed . B. Costall and R. J. Naylor, CNS Neurol. Disord.: Drug Targets, 2004, 3, 27–37 CAS . L. H. Tecott, A. V. Maricq and D. Julius, Proc. Natl. Acad. Sci., 1993, 90, 1430–1434 CrossRef CAS . A. Motavallian, M. Minaiyan, M. Rabbani, S. Andalib and P. Mahzouni, Bioimpacts, 2013, 3, 169–176 Search PubMed . L. Dupont, J. Pype, M. Demedts, P. De Leyn, G. Deneffe and G. Verleden, Eur. Respir. J., 1999, 14, 642–649 CrossRef CAS PubMed . B. Fiebich, R. Akundi, K. Lieb, E. Candelario-Jalil, D. Gmeiner, U. Haus, W. Müller, T. Stratz and E. Munoz, Scand. J. Rheumatol., 2004, 33, 28–32 CrossRef . G. Fakhfouri, R. Rahimian, J.-E. Ghia, W. I. Khan and A. R. Dehpour, Drug Discovery Today, 2012, 17, 741–747 CrossRef CAS PubMed . M. Schaalan, H. S. El-Abhar, M. Barakat and E. S. El-Denshary, J. Diabetes Complications, 2009, 23, 199–208 CrossRef PubMed . S. Saleh, N. El-Maraghy, E. Reda and W. Barakat, An. Acad. Bras. Cienc., 2014, 86, 1935–1948 CrossRef PubMed . H. B. H. Khan, K. S. Vinayagam, B. T. Moorthy, S. Palanivelu and S. Panchanatham, Inflammopharmacology, 2013, 21, 37–46 CrossRef PubMed . H. S. El-Abhar and M. F. Schaalan, PLoS One, 2012, 7, e37757 CAS . H. N. Boyda, R. M. Procyshyn, Y. Asiri, C. Wu, C. K. Wang, R. Lo, C. C. Pang, W. G. Honer and A. M. Barr, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 2014, 48, 170–176 CrossRef CAS PubMed . R. Rahimian, A. Daneshmand, S. E. Mehr, A. Barzegar-Fallah, S. Mohammadi-Rick, G. Fakhfouri, A. P. Shabanzadeh and A. R. Dehpour, Brain Res., 2011, 1392, 101–109 CrossRef CAS PubMed . D. Matthews, J. Hosker, A. Rudenski, B. Naylor, D. Treacher and R. Turner, Diabetologia, 1985, 28, 412–419 CrossRef CAS PubMed . A. Astrup and N. Finer, Obesity Rev., 2000, 1, 57–59 CrossRef CAS PubMed . J. Richmond, A. Codignola, I. Cooke and E. Sher, Pflügers Archiv, 1996, 432, 258–269 CrossRef CAS PubMed . S. Rohrer, B. A. Menge, L. Grüber, C. F. Deacon, W. E. Schmidt, J. D. Veldhuis, J. J. Holst and J. J. Meier, J. Clin. Endocrinol. Metab., 2012, 97, E791–E795 CrossRef CAS PubMed . C. J. Nolan, P. Damm and M. Prentki, J.-Lancet, 2011, 378, 169–181 CrossRef . A. G. Tabák, M. Jokela, T. N. Akbaraly, E. J. Brunner, M. Kivimäki and D. R. Witte, J.-Lancet, 2009, 373, 2215–2221 CrossRef . S. Skovsø, J. Diabetes Invest., 2014, 5, 349–358 CrossRef PubMed . F. Carvalho, D. Barros, J. Silva, E. Rezende, M. Soares, J. Fregoneze and E. de Castro-E-Silva, Horm. Metab. Res., 2005, 37, 482–488 CrossRef CAS PubMed . L. Kennedy and J. Baynes, Diabetologia, 1984, 26, 93–98 CrossRef CAS PubMed . D. Suzuki, M. Toyoda, N. Yamamoto, M. Miyauchi, M. Katoh, M. Kimura, M. Maruyama, M. Honma, T. Umezono and M. Yagame, Intern. Med., 2006, 45, 435–441 CrossRef . D. M. Abo-Elmatty, S. S. Essawy, J. M. Badr and O. Sterner, J. Ethnopharmacol., 2013, 145, 269–277 CrossRef CAS PubMed . M. Y. Donath, D. J. Gross, E. Cerasi and N. Kaiser, Diabetes, 1999, 48, 738–744 CrossRef CAS PubMed . R. MacKenzie and M. Trulson, J. Neurochem., 1978, 30, 205–211 CrossRef CAS PubMed . J. Malyszko, T. Urano, R. Knofler, A. Taminato, T. Yoshimi, Y. Takada and A. Takada, Thromb. Res., 1994, 75, 569–576 CrossRef CAS PubMed . F. Marti, J. Mi, M. Aldegunde and G. Atienza, Life Sci., 1994, 56, 51–59 CrossRef . J. D. Fernstrom and R. Wurtman, Science, 1971, 173, 149–152 CAS . R. o. Herrera, G. Manjarrez, E. Nishimura and J. Hernandez, J. Pediatr. Neurol., 2003, 28, 20–23 CrossRef . S. Ahmad, S. Tabassum and S. Haider, J. Pak. Med. Assoc., 2013, 63, 65–68 Search PubMed . B. Madras, E. Cohen, J. Fernstrom, F. Larin, H. Munro and R. Wurtman, Nature, 1973, 244, 34–35 CrossRef CAS PubMed . B. K. Madras, E. L. Cohen, R. Messing, H. N. Munro and R. J. Wurtman, Metabolism, 1974, 23, 1107–1116 CrossRef CAS PubMed . G. Curzon and C. Marsden, J. Neurochem., 1975, 25, 251–256 CrossRef CAS PubMed . C. Cangiano, A. Laviano, M. Del Ben, I. Preziosa, F. Angelico, A. Cascino and F. Rossi-Fanelli, Int. J. Obes., 1998, 22, 648–654 CrossRef CAS PubMed . G. Atienza, M. Andres, E. Rebolledo and M. Aldegunde, Neurochem. Res., 1992, 17, 289–292 CrossRef CAS PubMed . S. Russo, I. P. Kema, R. M. Fokkema, J. C. Boon, P. H. Willemse, E. G. de Vries, J. A. Den Boer and J. Korf, Psychosom. Med., 2003, 65, 665–671 CrossRef CAS PubMed . V. Fierabracci, M. Novelli, A. Ciccarone, P. Masiello, L. Benzi, R. Navalesi and E. Bergamini, Diabetes Metab., 1996, 22, 51–56 CAS . I. Hwang, E.-y. Seo and H. Ha, Arch. Pharmacal Res., 2009, 32, 1653–1662 CrossRef CAS PubMed . B. Rooney, H. O'Donovan, A. Gaffney, M. Browne, N. Faherty, S. P. Curran, D. Sadlier, C. Godson, D. P. Brazil and J. Crean, FEBS lett., 2011, 585, 531–538 CrossRef CAS PubMed . K.-m. YANG, X.-s. HU and H.-j. YANG, Chinese Journal of Diabetes, 2011, 19, 149–151 CAS . W. Liu, X. Liang and D. Yang, Evid.-Based Complement. Altern. Med., 2015, 501, 295135 Search PubMed . X.-L. Sun, Y. Liu, M.-H. Shi, W. Zhong, Z. Hong, H. Yang, S. Sen, X.-Y. Zhou, L.-X. Nie and Y.-Z. He, Chinese Journal of Endocrinology and Metabolism, 2011, 27, 57–61 CAS . A.-j. Huo, J.-f. Ma, L.-n. Yang, L.-x. Sun and L.-n. Wang, Chinese Journal of Blood Purification, 2012, 11, 33–37 Search PubMed . J. Jang, J.-H. Ha, S.-I. Chung and Y. Yoon, Int. J. Mol. Med., 2014, 34, 632–638 CrossRef CAS PubMed . J. Jang, J.-H. Ha, S.-M. Kim, W. Kim, K. Kim, S.-I. Chung and Y. Yoon, Mol. Med. Rep., 2014, 9, 633–638 CrossRef CAS PubMed . A. A. Soubh, D. M. Abdallah and H. S. El-Abhar, Life Sci., 2015, 136, 142–150 CrossRef CAS PubMed . Y.-J. Ho, W.-P. Chen, T.-C. Chi, C. Chang Chien, A.-S. Lee, H.-L. Chiu, Y.-H. Kuo and M.-J. Su, Cardiovasc. Diabetol., 2013, 12, 99–110 CrossRef CAS PubMed . M. M. Amin, G. F. Asaad, R. M. A. Salam, H. S. El-Abhar and M. S. Arbid, PLoS One, 2014, 9, e89169 Search PubMed . L. Cubeddu, H. Bönisch, M. Göthert, G. Molderings, K. Racke, G. Ramadori, K. Miller and H. Schwörer, Naunyn-Schmiedeberg's Arch. Pharmacol., 2000, 361, 85–91 CrossRef CAS PubMed . A. D. Miller and S. Nonaka, J. Pharmacol. Exp. Ther., 1992, 260, 509–517 CAS . J. Hawthorn, K. Ostler and P. Andrews, Q. J. Exp. Physiol., 1988, 73, 7–21 CrossRef CAS PubMed . L. X. Cubeddu, I. S. Hoffmann, N. T. Fuenmayor and A. L. Finn, N. Engl. J. Med., 1990, 322, 810–816 CrossRef CAS PubMed . A. Fuangchan, P. Sonthisombat, T. Seubnukarn, R. Chanouan, P. Chotchaisuwat, V. Sirigulsatien, K. Ingkaninan, P. Plianbangchang and S. T. Haines, J. Ethnopharmacol., 2011, 134, 422–428 CrossRef PubMed . Y. Tanaka, H. Uchino, T. Shimizu, H. Yoshii, M. Niwa, C. Ohmura, N. Mitsuhashi, T. Onuma and R. Kawamori, Eur. J. Pharmacol., 1999, 376, 17–22 CrossRef CAS PubMed . K. Isoda, J. L. Young, A. Zirlik, L. A. MacFarlane, N. Tsuboi, N. Gerdes, U. Schönbeck and P. Libby, Arterioscler., Thromb., Vasc. Biol., 2006, 26, 611–617 CrossRef CAS PubMed . A. Markowska, M. Pawałowska, V. Filas, K. Korski, M. Gryboś, S. Sajdak, A. Olejek, W. Bednarek, B. Śpiewankiewicz and J. Lubin, Diabetol. Metab. Syndr., 2013, 5, 76–87 CrossRef PubMed . G. Patanè, S. Piro, A. M. Rabuazzo, M. Anello, R. Vigneri and F. Purrello, Diabetes, 2000, 49, 735–740 | en_US |
| dc.identifier.doi | https://doi.org/10.1039/C7RA13105 | |
| dc.identifier.other | https://doi.org/10.1039/C7RA13105 | |
| dc.identifier.uri | https://cutt.ly/arItR5T | |
| dc.language.iso | en | en_US |
| dc.publisher | The Royal Society of Chemistr | en_US |
| dc.relation.ispartofseries | RSC Advances | |
| dc.subject | Tropisetron | en_US |
| dc.subject | glycation | en_US |
| dc.title | Tropisetron modulates peripheral and central serotonin/insulin levels via insulin and nuclear factor kappa B/receptor for advanced glycation end products signalling to regulate type-2 diabetes in rats | en_US |
| dc.type | Article | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 51 B
- Format:
- Item-specific license agreed upon to submission
- Description: